{
  "_id": "68028e9d3ccffd1c7912c90f",
  "ipo_id": "2023_mankind_pharma_limited_ipo",
  "__v": 0,
  "_metadata": {
    "sectionsAvailable": {
      "basicDetails": true,
      "tentativeSchedule": true,
      "lotSize": true,
      "timeline": false,
      "kpi": true,
      "financials": true,
      "promoterHolding": true,
      "objectives": false,
      "about": true,
      "subscriptionStatus": true,
      "contactDetails": true,
      "registrarDetails": true,
      "leadManagers": true,
      "listingDetails": true,
      "listingDayTrading": true,
      "faqs": true,
      "recommendationSummary": true,
      "prospectusLinks": true,
      "reservation": true,
      "anchorInvestors": true
    },
    "scrapedAt": "2025-04-18T17:33:55.280Z",
    "sourceUrl": "https://www.chittorgarh.com/ipo/mankind-pharma-ipo/1412/"
  },
  "about": {
    "details": "<p>Incorporated in 1991, Mankind Pharma Limited <strong>develops, manufactures, and markets pharmaceutical formulations across various acute and chronic therapeutic areas and several consumer healthcare products.</strong></p>\n<p>In India, the business is active in a number of acute and chronic therapeutic fields, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients, and respiratory.</p>\n<p>It <strong>has over 36 brands,</strong> including Manforce (Rx), Moxikind-CV, Amlokind-AT, Unwanted-Kit, Candiforce, Gudcef, Glimestar-M, Prega News, Dydroboon, Codistar, Nurokind-Gold, Nurokind Plus-RF, Nurokind-LC, Asthakind-DX, Cefakind, Monticope, Telmikind-H, Telmikind, Gudcef-CV, and Unwanted-72, among them.</p>\n<p>Mankind Pharma has one of the largest distribution networks of medical representatives in the Indian pharmaceutical market. Over <strong>80% of doctors in India prescribed their formulations</strong> and has been ranked number 4th in terms of domestic sales during the Financial Year 2022.</p>\n<p>The company has earned numerous awards and recognitions and including The Best of Bharat Awards 2022 by exchange4media in the year 2022, and Silver Medal from National Awards for Manufacturing Competitiveness Assessment 2021 instituted by International Research Institute for Manufacturing.</p>\n<p>Mankind has a pan-India marketing presence, with a field force of 11,691 medical representatives and 3,561 field managers, as of December 31, 2022. They operate 25 manufacturing facilities across India and had 4,121 manufacturing personnel as of December 31, 2022.</p>\n<p>As of December 31, 2022, the Company had a team of over 600 scientists and a dedicated in-house R&amp;D center with four units located in IMT Manesar, Gurugram, Haryana and Thane, Maharashtra.</p>"
  },
  "additionalTables": [
    {
      "heading": "Company Financials",
      "sanitizedHeading": "financials",
      "headers": [
        "Period Ended",
        "Total Assets",
        "Total Revenue",
        "Profit After Tax",
        "Net Worth",
        "Reserves and Surplus",
        "Total Borrowing"
      ],
      "rows": [
        [
          "31-Mar-20",
          "5073.29",
          "5975.65",
          "1056.15",
          "3485.31",
          "3436.34",
          "126.92"
        ],
        [
          "31-Mar-21",
          "6372.63",
          "6385.38",
          "1293.03",
          "4722.00",
          "4674.39",
          "234.53"
        ],
        [
          "31-Dec-21",
          "8043.88",
          "6218.29",
          "1260.24",
          "5965.46",
          "5916.86",
          "268.70"
        ],
        [
          "31-Mar-22",
          "9147.74",
          "7977.58",
          "1452.96",
          "6155.23",
          "6106.06",
          "868.03"
        ],
        [
          "31-Dec-22",
          "9273.75",
          "6777.82",
          "1015.98",
          "7145.89",
          "7094.12",
          "167.93"
        ]
      ]
    },
    {
      "heading": "Mankind Pharma Limited Stock Quote & Charts",
      "sanitizedHeading": "mankind_pharma_stock_quote_charts",
      "headers": [
        "KPI",
        "Values"
      ],
      "rows": [
        [
          "ROE",
          "27.60%"
        ],
        [
          "ROCE",
          "26.10%"
        ],
        [
          "RoNW",
          "27.70%"
        ]
      ]
    },
    {
      "heading": "Mankind Pharma Limited Stock Quote & Charts",
      "sanitizedHeading": "mankind_pharma_stock_quote_charts",
      "headers": [
        null,
        "Pre IPO",
        "Post IPO"
      ],
      "rows": [
        [
          "EPS (Rs)",
          "33.20",
          null
        ],
        [
          "P/E (x)",
          "32.5",
          null
        ]
      ]
    }
  ],
  "anchorInvestors": {
    "summary": "Mankind Pharma IPO raises Rs 1297.91 crore from anchor investors. Mankind Pharma IPO Anchor bid date is April 24 2023. Mankind Pharma IPO Anchor Investors list",
    "list_link": {
      "text": "Mankind Pharma IPO Anchor Investors list",
      "url": "https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20230424-36&attachedId=d86029da-fa52-4373-99e2-2408da5eb5e4"
    },
    "details": {
      "ipo_date": "August 1 2023",
      "shares_offered": "12017652",
      "anchor_portion_size": "1297.91"
    }
  },
  "basicDetails": {
    "ipoDate": "April 25, 2023 to April 27, 2023",
    "ipoListingDate": "Tue, May 9, 2023",
    "faceValue": "₹1 per share",
    "issuePrice": "₹1,080.00",
    "lotSize": "13 Shares",
    "issueSize": "4,00,58,844 shares (aggregating up to ₹4,326.36 Cr)",
    "offerForSale": "4,00,58,844 shares of ₹1 (aggregating up to ₹4,326.36 Cr)",
    "issueType": "Bookbuilding IPO",
    "listingAt": "BSE, NSE",
    "ipoOpenDate": "Tue, Apr 25, 2023",
    "ipoCloseDate": "Thu, Apr 27, 2023",
    "initiationOfRefunds": "Thu, May 4, 2023",
    "creditOfSharesToDemat": "Fri, May 5, 2023",
    "shareHoldingPreIssue": "40,05,88,440 shares",
    "shareHoldingPreIssueAll": [
      {
        "label": "Share Holding Pre Issue",
        "value": "40,05,88,440 shares"
      },
      {
        "label": "Share Holding Pre Issue",
        "value": "79.00%"
      }
    ],
    "shareHoldingPostIssue": "40,05,88,440 shares",
    "shareHoldingPostIssueAll": [
      {
        "label": "Share Holding Post Issue",
        "value": "40,05,88,440 shares"
      },
      {
        "label": "Share Holding Post Issue",
        "value": "76.50%"
      }
    ]
  },
  "closing_date": "2023-04-26T18:30:00.000Z",
  "contactDetails": {
    "phone": "+91 11 4684 6700",
    "email": "investors@mankindpharma.com",
    "full_address": "Mankind Pharma Limited, 208 Okhla Industrial Estate, Phase-III, New Delhi 110020",
    "website": "https://www.mankindpharma.com/"
  },
  "createdAt": "2025-04-18T17:40:44.986Z",
  "faqs": [
    {
      "question": "What is the Mankind Pharma IPO?",
      "answer": "<div itemprop=\"text\"><p>Mankind Pharma IPO<!-- --> is a <b>main-board<!-- --> <!-- -->IPO<!-- --> of <!-- -->40058844<!-- --> equity shares</b> of the face value of ₹<!-- -->1<!-- --> aggregating up to ₹<!-- -->4,326.36<!-- --> Crores. The issue is priced at <span>₹1080 per share</span>. The minimum order quantity is <!-- -->13<!-- -->.</p><p>The <!-- -->IPO<!-- --> <b>opens on <!-- -->April 25, 2023</b>, and <b>closes on <!-- -->April 27, 2023</b>.</p><p>Kfin Technologies Limited<!-- --> is the registrar for the <!-- -->IPO<!-- -->. The shares are proposed to be listed on <!-- -->BSE, NSE<!-- -->.</p></div>"
    },
    {
      "question": "How to apply in Mankind Pharma IPO through Zerodha?",
      "answer": "<div itemprop=\"text\"><p>Zerodha customers can apply online in <!-- -->Mankind Pharma IPO<!-- --> using UPI as a payment gateway. Zerodha customers can apply in <!-- -->Mankind Pharma IPO<!-- --> by login into Zerodha Console (back office) and submitting an IPO application form.</p><p><strong>Steps to apply in <!-- -->Mankind Pharma IPO<!-- --> through Zerodha</strong></p><ol><li>Visit the Zerodha website and login to Console.</li><li>Go to Portfolio and click the IPOs link.</li><li>Go to the '<!-- -->Mankind Pharma IPO<!-- -->' row and click the 'Bid' button.</li><li>Enter your UPI ID, Quantity, and Price.</li><li>Submit IPO application form.</li><li>Visit the UPI App (net banking or BHIM) to approve the mandate.</li></ol><p>Visit <a href=\"/broker/zerodha/ipo/18/\" title=\"Zerodha IPO Application Process Review\">Zerodha IPO Application Process Review</a> for more detail.</p></div>"
    },
    {
      "question": "When Mankind Pharma IPO will open?",
      "answer": "<div itemprop=\"text\"><p>The Mankind Pharma IPO opens on April 25, 2023 and closes on April 27, 2023.</p></div>"
    },
    {
      "question": "What is the lot size of Mankind Pharma IPO?",
      "answer": "<div itemprop=\"text\"><p>Mankind Pharma IPO<!-- --> <b>lot size is <!-- -->13</b>, and the <b>minimum amount required is <span>₹14,040</span></b>.</p></div>"
    },
    {
      "question": "How to apply for Mankind Pharma IPO?",
      "answer": "<div itemprop=\"text\"><p>You can apply in <!-- -->Mankind Pharma IPO<!-- --> online using either <a href=\"/article/upi-payment-option-ipo-application-explained/382/\">UPI</a> or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through <a href=\"/broker/zerodha/ipo/18/\" title=\"Zerodha IPO Review\"><b>Zerodha</b></a>, <a href=\"/broker/upstox/ipo/33/\" title=\"Upstox IPO Review\">Upstox</a>, <a href=\"/broker/5paisa/ipo/4/\" title=\"5Paisa IPO Review\">5Paisa</a>, <a href=\"/broker/edelweiss_broking/ipo/34/\" title=\"Nuvama IPO Review\">Nuvama</a>, <a href=\"/broker/hdfc-securities/ipo/6/\" title=\"HDFC Bank IPO Review\">HDFC Bank</a>, and <a href=\"/broker/sbi-capital/ipo/19/\" title=\"SBI Capital IPO Review\">SBI Bank</a>.</p></div>"
    },
    {
      "question": "When is Mankind Pharma IPO allotment?",
      "answer": "<div itemprop=\"text\"><p>The finalization of Basis of Allotment for <!-- -->Mankind Pharma IPO<!-- --> will be done on <!-- -->Wednesday, May 3, 2023<!-- -->, and the allotted shares will be credited to your demat account by <!-- -->Friday, May 5, 2023<!-- -->. Check the <a href=\"/ipo_allotment_status/mankind-pharma-ipo/1412/\" title=\"Mankind Pharma IPO Allotment Status\">Mankind Pharma IPO<!-- --> allotment status</a>.</p></div>"
    },
    {
      "question": "When is Mankind Pharma IPO listing date?",
      "answer": "<div itemprop=\"text\"><p>The <!-- -->Mankind Pharma IPO<!-- --> listing date is on <b>Tuesday, May 9, 2023</b>.</p></div>"
    }
  ],
  "ipoName": "Mankind Pharma",
  "issue_price": "₹1,080.00",
  "issue_price_numeric": 1,
  "issue_size": "4,00,58,844 shares (aggregating up to ₹4,326.36 Cr)",
  "issue_size_numeric": 4,
  "leadManagerReports": [
    {
      "text": "IPO Lead Manager Performance Summary",
      "url": "/report/ipo_lead_manager_performance_tracker/19/"
    },
    {
      "text": "IPO Lead Manager Performance Tracker",
      "url": "/report/ipo-lead-manager-vs-listing-gain/99/17/"
    }
  ],
  "leadManagers": [
    {
      "name": "Kotak Mahindra Capital Company Limited",
      "url": "/report/ipo-lead-manager-review/112/12/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/12/"
    },
    {
      "name": "Axis Capital Limited",
      "url": "/report/ipo-lead-manager-review/112/113/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/113/"
    },
    {
      "name": "Iifl Securities Ltd",
      "url": "/report/ipo-lead-manager-review/112/71/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/71/"
    },
    {
      "name": "Jefferies India Private Limited",
      "url": "/report/ipo-lead-manager-review/112/112/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/112/"
    },
    {
      "name": "J.P. Morgan India Private Limited",
      "url": "/report/ipo-lead-manager-review/112/19/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/19/"
    }
  ],
  "listingDayTrading": {
    "data": {
      "final_issue_price": {
        "bse": "1080.00",
        "nse": "1080.00"
      },
      "open": {
        "bse": "1300.00",
        "nse": "1300.00"
      },
      "low": {
        "bse": "1300.00",
        "nse": "1300.00"
      },
      "high": {
        "bse": "1430.00",
        "nse": "1430.00"
      },
      "last_trade": {
        "bse": "1424.05",
        "nse": "1080.00"
      }
    },
    "performance_link": {
      "text": "Check IPO Performance…",
      "url": "/ipo/ipo_perf_tracker.asp"
    }
  },
  "listingDetails": {
    "pre_open_links": [
      {
        "text": "Pre-Open Session - NSE",
        "url": "https://www.nseindia.com/market-data/new-stock-exchange-listings-today"
      },
      {
        "text": "Pre-Open Session - BSE",
        "url": "https://www.bseindia.com/eqstreamer/StockTickerSplPreOpen.html"
      }
    ],
    "ipo_date": "May 9 2023",
    "bse_script_code": "543904",
    "nse_symbol": "MANKIND",
    "isin": "INE634S01028",
    "final_issue_price": "1080 per share"
  },
  "listing_date": "2023-05-08T18:30:00.000Z",
  "listing_gains": "31.86%",
  "listing_gains_numeric": 31.86,
  "logo": "https://www.chittorgarh.net/images/ipo/mankind-pharma-logo.png",
  "logo_url": "https://www.chittorgarh.net/images/ipo/mankind-pharma-logo.png",
  "lotSize": {
    "summary": "Investors can bid for a minimum of 13 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.",
    "applications": {
      "retail_min": {
        "application": "Retail (Min)",
        "lots": "1",
        "shares": "13",
        "amount": "14040"
      },
      "retail_max": {
        "application": "Retail (Max)",
        "lots": "14",
        "shares": "182",
        "amount": "196560"
      },
      "shni_min": {
        "application": "S-HNI (Min)",
        "lots": "15",
        "shares": "195",
        "amount": "210600"
      },
      "shni_max": {
        "application": "S-HNI (Max)",
        "lots": "71",
        "shares": "923",
        "amount": "996840"
      },
      "bhni_min": {
        "application": "B-HNI (Min)",
        "lots": "72",
        "shares": "936",
        "amount": "1010880"
      },
      "lot_size": {
        "application": "Lot Size Calculator"
      }
    },
    "calculator_link": {
      "text": "Lot Size Calculator",
      "url": "/ipo-hni-funding-cost-calculator/mankind-pharma-ipo/1412/"
    }
  },
  "lot_size": 13,
  "opening_date": "2023-04-24T18:30:00.000Z",
  "pageHeading": "Mankind Pharma Limited IPO (Mankind Pharma IPO) Detail",
  "pageTitle": "Mankind Pharma IPO Date, Price, GMP, Review, Details",
  "promoterHolding": {
    "promoters": "Ramesh Juneja Rajeev Juneja Sheetal Arora Ramesh Juneja Family Trust Rajeev Juneja Family Trust and Prem Sheetal Family Trust are the company promoters.",
    "holdings": {
      "share_holding_pre_issue": "79.00%",
      "share_holding_post_issue": "76.50%"
    },
    "note": "The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue"
  },
  "prospectusLinks": [
    {
      "text": "Mankind Pharma IPO DRHP",
      "url": "https://www.sebi.gov.in/filings/public-issues/sep-2022/mankind-pharma-ltd-drhp_63010.html"
    },
    {
      "text": "Mankind Pharma IPO RHP",
      "url": "https://www.sebi.gov.in/filings/public-issues/may-2023/mankind-pharma-limited-prospectus_71518.html"
    },
    {
      "text": "Anchor Investors in Mankind Pharma IPO",
      "url": "https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20230424-36&attachedId=d86029da-fa52-4373-99e2-2408da5eb5e4"
    }
  ],
  "recommendationSummary": {
    "recommendations": {
      "brokersbrokers": {
        "subscribe": "13",
        "neutral": "0",
        "avoid": "0"
      },
      "membersmembers": {
        "subscribe": "9",
        "neutral": "4",
        "avoid": "12"
      }
    },
    "links": [
      {
        "text": "Read All Reviews",
        "url": "/ipo-recommendation/mankind-pharma-ipo/1412/"
      },
      {
        "text": "Post Your Review",
        "url": "#"
      },
      {
        "text": "Manage Reviews",
        "url": "#"
      }
    ]
  },
  "registrarDetails": {
    "name": "Kfin Technologies Limited",
    "phone": "04067162222 04079611000",
    "email": "mankind.ipo@kfintech.com",
    "website": "https://kosmic.kfintech.com/ipostatus/"
  },
  "reservation": {
    "summary": "Mankind Pharma IPO offers 40058844 shares. 8011769 (20.00%) to QIB 6008827 (15.00%) to NII 14020596 (35.00%) to RII 12017652 (30.00%) to Anchor investors. 1078507 RIIs will receive minimum 13 shares and 10271 (sNII) and 20543 (bNII) will receive minimum 195 shares. (in case of oversubscription)",
    "allocation": [
      {
        "investor_category": "Anchor Investor Shares Offered",
        "shares_offered": "12017652 (30.00%)",
        "maximum_allottees": "NA"
      },
      {
        "investor_category": "QIB Shares Offered",
        "shares_offered": "8011769 (20.00%)",
        "maximum_allottees": "NA"
      },
      {
        "investor_category": "NII (HNI) Shares Offered",
        "shares_offered": "6008827 (15.00%)"
      },
      {
        "investor_category": "bNII > 10L",
        "shares_offered": "4005885 (10.00%)",
        "maximum_allottees": "20543"
      },
      {
        "investor_category": "sNII < 10L",
        "shares_offered": "2002942 (5.00%)",
        "maximum_allottees": "10271"
      },
      {
        "investor_category": "Retail Shares Offered",
        "shares_offered": "14020596 (35.00%)",
        "maximum_allottees": "1078507"
      },
      {
        "investor_category": "Total Shares Offered",
        "shares_offered": "40058844 (100%)"
      }
    ]
  },
  "scraped_at": "2025-04-18T17:40:44.985Z",
  "source_url": "",
  "status": "listed",
  "subscriptionStatus": {
    "summary": "The Mankind Pharma IPO is subscribed 15.32 times on April 27 2023 7:02:00 PM (Day 3). The public issue subscribed 0.92 times in the retail category 49.16 times in the QIB category and 3.8 times in the NII category. Check Day by Day Subscription Details (Live Status)",
    "overall": {
      "qib": {
        "category": "QIB",
        "subscription_times": "49.16",
        "shares_offered": "8011769",
        "shares_bid_for": "393834103"
      },
      "nii": {
        "category": "NII",
        "subscription_times": "3.8",
        "shares_offered": "6008827",
        "shares_bid_for": "22822761"
      },
      "bnii": {
        "category": "bNII (bids above 10L)",
        "subscription_times": "4.99",
        "shares_offered": "4005885",
        "shares_bid_for": "20000500"
      },
      "snii": {
        "category": "sNII (bids below 10L)",
        "subscription_times": "1.41",
        "shares_offered": "2002942",
        "shares_bid_for": "2822261"
      },
      "retail": {
        "category": "Retail",
        "subscription_times": "0.92",
        "shares_offered": "14020596",
        "shares_bid_for": "12856038"
      },
      "total": {
        "category": "Total",
        "subscription_times": "15.32",
        "shares_offered": "28041192",
        "shares_bid_for": "429512902"
      }
    },
    "total_applications": "462789"
  },
  "tentativeDetails": {
    "ipo_date": "5 PM on April 27 2023",
    "tentative_allotment": "Wed May 3 2023",
    "initiation_of_refunds": "Thu May 4 2023",
    "credit_of_shares_to_demat": "Fri May 5 2023"
  },
  "updatedAt": "2025-04-19T04:37:37.160Z",
  "updated_at": "2025-04-18T17:40:44.985Z",
  "year": 2023,
  "worst_listing_gains": "31.86%",
  "worst_listing_gains_numeric": 31.86
}